EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell Cultures

Patricia Gassó iD, Albert Martínez-Pinteño iD, Natalia Rodríguez iD, Santiago Madero, Marta Gómez, Alex G Segura, Clemente García-Rizo, Constanza Morén iD, Sergi Mas, Eduard Parellada

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Patricia Gassó und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Clinical Practice, University of Barcelona, 08036 Barcelona, Spain. Hauptthemen laut MEDLINE: Clozapine, Neuroprotective Agents, Neuroblastoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union, Catalan Pons Balmes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current antipsychotics (APs) effectively control positive psychotic symptoms, mainly by blocking dopamine (DA) D2 receptors, but have little effect on negative and cognitive symptoms. Increased glutamate (GLU) release would trigger neurotoxicity, leading to apoptosis and synaptic pruning, which is involved in the pathophysiology of schizophrenia. New pharmacological strategies are being developed such as positive allosteric modulators (PAMs) of the metabotropic GLU receptor 2 (mGluR2) that inhibit the presynaptic release of GLU. We previously reported that treatment of adult mice with JNJ-46356479 (JNJ), a recently developed mGluR2 PAM, partially improved neuropathological deficits and schizophrenia-like behavior in a postnatal ketamine mouse model. In the present study, we evaluated, for the first time, the putative neuroprotective and antiapoptotic activity of JNJ in a human neuroblastoma cell line and compared it with the effect of clozapine (CLZ) as a clinical AP with the highest efficacy and with apparent utility in managing negative symptoms. Specifically, we measured changes in cell viability, caspase 3 activity and apoptosis, as well as in the expression of key genes involved in survival and cell death, produced by CLZ and JNJ alone and in combination with a high DA or GLU concentration as apoptosis inducers. Our results suggest that JNJ is not neurotoxic and attenuates apoptosis, particularly by decreasing the caspase 3 activation induced by DA and GLU, as well as increasing and decreasing the number of viable and apoptotic cells, respectively, only when cultures were exposed to GLU. Its effects seem to be less neurotoxic and more neuroprotective than those observed with CLZ. Moreover, JNJ partially normalized altered expression levels of glycolytic genes, which could act as a protective factor and be related to its putative neuroprotective effect. More studies are needed to define the mechanisms of action of this GLU modulator and its potential to become a novel therapeutic agent for schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineNeuroprotective AgentsNeuroblastomaAdultHumansMiceAnimalsCaspase 3Glutamic AcidCell Culture TechniquesAllosteric RegulationReceptors, Metabotropic Glutamate

Stichwörter der Autor:innen

JNJ-46356479antipsychoticapoptosismGluR2positive allosteric modulatorschizophrenia

Substanzen

ClozapineNeuroprotective AgentsCaspase 3Glutamic Acidmetabotropic glutamate receptor 2Receptors, Metabotropic Glutamate

Autor:innen und Institutionen

  • Department of Basic Clinical Practice, University of Barcelona, 08036 Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), 28029 Madrid, Spain.
  • Barcelona Clínic Schizophrenia Unit (BCSU), Department of Psychiatry, Institute of Neuroscience, Hospital Clínic of Barcelona, University of Barcelona, 08036 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.

ORCID-Profile: Patricia Gassó, Albert Martínez-Pinteño, Natalia Rodríguez, Constanza Morén

Förderung

  • Instituto de Salud Carlos III
  • European Union
  • Catalan Pons Balmes
  • Government of Catalonia, Secretaria d′ Universitats i Recerca del Departament d′Economia I Coneixement

Zitieren

APA

Gassó, P., Martínez-Pinteño, A., Rodríguez, N., Madero, S., Gómez, M., Segura, A. G., García-Rizo, C., Morén, C., Mas, S., & Parellada, E. (2023). Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell Cultures. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032054

Vancouver

Gassó P, Martínez-Pinteño A, Rodríguez N, Madero S, Gómez M, Segura AG, et al. Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell Cultures. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032054

BibTeX
@article{Gass2023,
  author = {Gassó, Patricia and Martínez-Pinteño, Albert and Rodríguez, Natalia and Madero, Santiago and Gómez, Marta and Segura, Alex G and García-Rizo, Clemente and Morén, Constanza and Mas, Sergi and Parellada, Eduard},
  title = {Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell Cultures},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032054}
}
Kostenlos starten →